WCAMG
PFE icon

Woodard & Company Asset Management Group’s Pfizer PFE Stock Holding History

Woodard & Company Asset Management Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,818
Closed -$76K – 178
2018
Q3 		$76K Hold
1,818
– – 0.07% 74
2018
Q2 		$62.6K Sell
1,818
-1,370
-43% -$46.8K 0.06% 79
2018
Q1 		$107K Sell
3,188
-262
-8% -$9.01K 0.1% 60
2017
Q4 		$118K Buy
+3,450
New +$118K 0.1% 62

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Woodard & Company Asset Management Group's PFE Position: Q4 2018 in Review

Woodard & Company Asset Management Group sold out of Pfizer (PFE) in Q4 2018, closing a stake of 1,818 shares — an estimated $76K sold.

Woodard & Company Asset Management Group first reported a position in PFE in Q4 2017 and held it in 4 quarters. The position peaked at $118K in Q4 2017. 2,404 funds tracked by Wall St. Rank hold PFE as of Q4 2018.

  • Woodard & Company Asset Management Group reported no remaining Pfizer position as of Q4 2018 after selling out during the quarter.
  • Woodard & Company Asset Management Group sold 1,818 Pfizer shares in Q4 2018, an estimated $76K.
  • Woodard & Company Asset Management Group first reported a position in Pfizer in Q4 2017 and held it in 4 quarters.
  • Woodard & Company Asset Management Group's Pfizer position peaked at $118K in Q4 2017.
  • 2,404 funds tracked by Wall St. Rank held Pfizer as of Q4 2018.

Based on Woodard & Company Asset Management Group's 13F filing for Q4 2018, filed 1 Feb 2019.